Hikma Pharmaceuticals (HKMPY)

PNK: HKMPY · Real-Time Price · USD

52.97

0.00 (0.00%)

At close: Apr 30, 2025, 3:45 PM

Hikma Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	188M	205M	270M	426M	323M	442M	276M	227M	155M
Short-Term Investments	25M	24M	22M	24M	24M	23M	21M	22M	20M
Long-Term Investments	51M	65M	53M	33M	24M	20M	17M	44M	-6M
Other Long-Term Assets	44M	48M	22M	24M	24M	23M	51M	22M	61M
Receivables	905M	789M	777M	781M	662M	637M	654M	650M	699M
Inventory	986M	891M	776M	695M	757M	568M	528M	488M	459M
Other Current Assets	86M	119M	80M	103M	100M	129M	132M	146M	71M
Total Current Assets	2.26B	2.1B	2B	2.09B	1.92B	1.85B	1.67B	1.57B	1.45B
Property-Plant & Equipment	1.33B	1.14B	1.08B	1.15B	1.07B	962M	870M	828M	969M
Goodwill & Intangibles	1.16B	1.1B	1.12B	892M	876M	834M	766M	785M	1.72B
Total Long-Term Assets	2.87B	2.58B	2.47B	2.28B	2.21B	2.08B	1.83B	1.81B	2.92B
Total Assets	5.13B	4.68B	4.47B	4.37B	4.13B	3.93B	3.5B	3.39B	4.36B
Account Payables	358M	309M	291M	262M	279M	286M	263M	218M	172M
Deferred Revenue	n/a	n/a	193M	294M	100M	105M	65M	382M	432M
Short-Term Debt	642M	150M	139M	112M	158M	569M	74M	86M	117M
Other Current Liabilities	863M	869M	173M	115M	70M	378M	397M	361M	377M
Total Current Liabilities	1.98B	1.34B	1.08B	1.02B	1.03B	1.47B	893M	797M	918M
Long-Term Debt	607M	975M	1.07B	651M	692M	48M	539M	670M	721M
Other Long-Term Liabilities	133M	77M	92M	140M	164M	203M	329M	324M	277M
Total Long-Term Liabilities	834M	1.13B	1.25B	889M	959M	330M	907M	1.06B	1.03B
Total Liabilities	2.81B	2.47B	2.32B	1.91B	1.99B	1.8B	1.8B	1.86B	1.95B
Total Debt	1.31B	1.19B	1.28B	846M	932M	685M	637M	777M	860M
Common Stock	40M	40M	40M	42M	41M	41M	40M	40M	40M
Retained Earnings	2.36B	2.16B	2.09B	2.19B	1.89B	1.97B	1.58B	1.38B	1.25B
Comprehensive Income	n/a	-282M	-279M	-60M	-80M	-178M	-216M	-189M	829M
Shareholders Equity	2.31B	2.2B	2.13B	2.45B	2.13B	2.12B	1.69B	1.51B	2.4B
Total Investments	76M	83M	75M	57M	48M	43M	68M	66M	55M